Naveen Kumar Amar joins the surgical robot developer as it prepares to expand globally, including in Europe and the U.S.
The device, called Biolinq Shine, is indicated for people with Type 2 diabetes who don’t depend on insulin. Biolinq says its ...
The request includes a call to postpone re-certification requirements for devices already certified under the medical ...
The Trump administration has used the investigations in other sectors to implement tariffs, but the earliest any potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback